GlassScriptPhysician profile
Joshua J Underhill
NPI 1245269778
$3,391.84
in general payments reported to CMS, 2019-2025
20 companies · $597 in 2025
The $597 reported for 2025 was more than what 95% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $216 · 2020: $133 · 2022: $536 · 2023: $990 · 2024: $920 · 2025: $597.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,507.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $840.92 | 2022-2025 | Qelbree, Qelbree |
| Corium, LLC | $656.37 | 2022-2025 | Azstarys |
| Kerecis Limited | $462.35 | 2020-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Tris Pharma INC | $356.19 | 2019-2025 | Dyanavel Xr |
| Ironshore Pharmaceuticals INC. | $324.29 | 2019-2024 | Jornay Pm |
| Glaxosmithkline, LLC. | $299.45 | 2019-2025 | Bexsero, Pediarix, Rotarix |
| Collegium Pharmaceutical, INC. | $136.58 | 2025 | Jornay Pm |
| Pfizer INC. | $60.83 | 2023-2025 | |
| Neurelis, INC. | $36.06 | 2022-2024 | Valtoco |
| Aytu Biopharma, INC. | $31.76 | 2024 | Karbinal |
| Cranial Technologies, INC | $30.01 | 2023-2024 | Doc Band |
| Sobi, INC | $27.72 | 2022-2023 | |
| Ironwood Pharmaceuticals, INC | $22.41 | 2024 | |
| Sanofi Pasteur INC. | $20.92 | 2023 | |
| Neos Therapeutics, LP | $16.99 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $15.02 | 2025 | Relexxii |
| Merck Sharp & Dohme LLC | $14.47 | 2019 | |
| Shire North American Group INC | $13.18 | 2019 | |
| Genentech USA, INC. | $13.18 | 2019 | |
| Seqirus USA INC | $13.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Underhill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.